ARCHIVES

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

Cancer researchers support “responsible” human stem cell research.

July 22, 2005

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004